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Abstract
Background Pemphigus is a chronic autoimmune blistering disease of the skin and mucosa severely impairing patients’ 
health-related quality of life (HRQoL). To date, no studies have measured subjective well-being in terms of life satisfac-
tion in pemphigus. Our main objective was to evaluate satisfaction with life in patients with pemphigus, and to analyse its 
relationship with clinical severity and HRQoL.
Methods A cross-sectional survey was carried out enrolling 77 patients with pemphigus. Subjective well-being was measured 
using the Satisfaction with Life Scale (SWLS). HRQoL was assessed by the Dermatology Life Quality Index (DLQI) and 
EQ-5D-5L. Disease severity was measured by Autoimmune Bullous Skin Disorder Intensity Score (ABSIS).
Results Mean ABSIS, DLQI, EQ-5D-5L and SWLS scores of patients were 11.7 (SD 17.3), 5.4 (6.8), 0.84 (0.22) and 4.76 
(SD 1.52), respectively. The proportion of patients indicating extreme dissatisfaction, dissatisfaction, slightly below aver-
age in life satisfaction, average satisfaction, high satisfaction and very high satisfaction with life was 6 (7.8%), 5 (6.5%), 
14 (18.2%), 16 (20.8%), 21 (27.3%) and 15 (19.5%), respectively. Life satisfaction was independent from age, gender, level 
of education and type of disease. A path analysis revealed that there was no direct relationship between ABSIS and SWLS 
(beta = − 0.09; p = 0.428); however, the following indirect path was confirmed: ABSIS → DLQI → EQ-5D-5L → SWLS.
Conclusions Disease severity and HRQoL measures regularly used to assess patients’ health status may be complemented 
with a measure of subjective well-being, such as SWLS, to achieve a more holistic assessment of patients’ lives and optimise 
pemphigus care.
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Introduction
Pemphigus is a rare, autoimmune blistering disease with two 
major subtypes pemphigus vulgaris and pemphigus foliaceus 
[1]. Pemphigus vulgaris accounts for approximately 70–90% of 
all cases with an annual incidence rate of 0.76–32 per million 
[2, 3]. Mean age of onset is usually between 50 and 60 years. 
Pemphigus causes blisters and erosions developing on the 
skin or mucous membranes, such as in the mouth. Physical 
symptoms include itching, skin burning and pain. Pemphigus 
has a strong influence on patients’ health-related quality of 
life (HRQoL), but it largely affects other aspects of patients’ 
life, such as social activities or productivity [4–6]. It has been 
shown that pemphigus is associated with one of the largest 
HRQoL impairment among chronic skin diseases [4, 5, 7–9].
Recently, subjective well-being has gained increasing atten-
tion in health policy. Subjective well-being reflects an overall 
evaluation of the quality of a person’s life from their own per-
spective [10]. Evidence on subjective measures of well-being 
is in the focus of interest to provide a basis for reimbursement 
decisions about health technologies [11]. To use well-being 
outcomes in resource allocation decisions, the relationship 
between subjective well-being and the different dimensions of 
health, such as clinical symptoms, disease-specific and general 
HRQoL, needs to be explored [12]. Life satisfaction is a core 
indicator of people’s subjective well-being. Satisfaction with 
life can be used as an outcome measure, as it is directly related 
to HRQoL. In patients suffering from chronic diseases, both 
physical and mental problems may have a substantial negative 
impact on satisfaction with life [13].
Patients’ interpersonal relationships, social activities, 
sexual life and self-esteem are commonly adversely affected 
by chronic dermatological diseases [14]. In addition, patients 
may be dissatisfied with treatments and healthcare in general. 
Unemployment rate was also found higher in chronic skin dis-
eases compared to health controls, and a proportion of patients 
also face a lower earning potential [15–18]. Dissatisfaction 
with life has been earlier reported in patients with atopic 
dermatitis, psoriasis, hidradenitis suppurativa, melanoma, 
systemic lupus erythematosus and urticaria [19–25]. Life sat-
isfaction, however, has not yet been measured in pemphigus 
patients. Therefore, our main objective was to evaluate the 
satisfaction with life in patients with pemphigus and to ana-
lyse the relationship between severity of clinical symptoms, 
HRQoL and life satisfaction as an indicator of subjective 
well-being.
Methods
Study population and setting
Between December 2014 and June 2017, a cross-sectional 
study was conducted in four academic dermatology depart-
ments in Hungary. Consecutive patients over 18 years of age 
diagnosed with any form of pemphigus were enrolled after 
an informed consent form was read and signed. Permission 
for conducting the study was granted by the National Sci-
entific and Ethical Committee (reference No. ETT-TUKEB 
27416-3/2016/EKU).
First part of the survey asked patients about demograph-
ics, employment status, self-reported disease severity, utili-
sation of healthcare services in the past 12 months, HRQoL, 
and satisfaction with life. Dermatologists filled in the second 
part of the questionnaire. Based on medical records they pro-
vided data on clinical characteristics, medications, medical 
history and disease severity.
Outcome measures
EQ‑5D‑5L
EQ-5D-5L is a widely used generic instrument to assess gen-
eral HRQoL [26, 27]. It consists of two parts: a descriptive 
system and a visual analogue scale (EQ VAS). The descrip-
tive system involves the following five dimensions of general 
HRQoL: mobility, self-care, usual activities, pain/discomfort 
and anxiety/depression. For each dimension, patients may 
choose from five response levels (no problems = 1, slight 
problems = 2, moderate problems = 3, severe problems = 4 
and unable to/extreme problems = 5) resulting in a total of 
3125  (55) unique health states. In the absence of a national 
value set in Hungary, the value set for England developed 
by Devlin et al. was applied in this study to derive EQ-5D 
index scores [28]. Thus, index scores may range from -0.285 
to + 1, where − 0.285 corresponds to the worst and +1 to the 
best possible HRQoL. The second part of the instrument, 
EQ VAS is a 20-cm long, vertical visual analogue scale 
with endpoints of ‘0’ (the worst health you can imagine) 
and ‘100’ (the best you can imagine) recording patients’ 
self-rating of their overall health.
DLQI
Dermatology Life Quality Index (DLQI) is a skin-specific 
self-reported questionnaire [29, 30]. It consists of ten items 
covering the common problems affecting HRQoL of patients 
with skin diseases, such as symptoms, side effects of treat-
ment, daily activities, work or school, personal relationships, 
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leisure activities, and feelings of embarrassment. Each item 
is scored on a 4-point scale: ‘not at all’ or ‘not relevant’ = 0, 
‘a little’ = 1, ‘a lot’ = 2 and ‘very much’ = 3. DLQI total score 
is calculated by summing the score of each question result-
ing in a maximum of 30 and a minimum of 0, where the 
higher the score, the more HRQoL is impaired.
SWLS
The Satisfaction with Life Scale (SWLS) is an extensively 
used questionnaire to quantify people’s global judgement 
on their subjective well-being [31]. The Hungarian version 
of SWLS showed a good internal consistency reliability 
(Cronbach’s α 0.84), convergent validity with the Rosenberg 
Self-esteem Scale and the Purpose in Life Test and an excel-
lent test–retest reliability [32]. SWLS is a five-item instru-
ment each of which is rated on a 7-point scale ranging from 
‘strongly disagree’ to ‘strongly agree’. The total score was 
estimated as the average of the five items resulting in a score 
between 1 and 7, where a higher score reflects a greater life 
satisfaction for the individual [31]. The following cut-off 
scores were used to classify patients into SWLS groups: 1–2 
(‘extremely dissatisfied’), 2–3 (‘dissatisfied’), 3–4 (‘slightly 
below average satisfaction’), 4–5 (‘average satisfaction’), 
5–6 (’satisfied’) and 6–7 (’highly satisfied’) [33].
ABSIS
Severity of pemphigus was graded using the Autoimmune 
Bullous Skin Disorder Intensity Score (ABSIS) [34–36]. 
The ABSIS total score ranges between 0 and 206, where 
a higher score indicates more severe disease. Subgroups of 
disease severity were defined based on the following cut-
off values: limited (ABSIS 0–3), moderate (ABSIS 4–16), 
significant (ABSIS 17–52) and extensive (ABSIS 53–206) 
pemphigus [37].
Statistical analysis
First, sample and SWLS item characteristics were computed. 
As a preliminary analysis, Pearson’s correlation coefficients 
were calculated to explore the relationships between the 
outcome measures. A correlation coefficient of 0–0.39 was 
defined as weak, 0.40–0.79 as moderate, and 0.80–1 as a 
strong correlation. The differences in SWLS scores between 
subgroups of patients were compared using Mann–Whitney 
U test.
We conducted a path analysis to test a hypothesized model 
predicting SWLS scores from EQ-5D-5L index, DLQI, 
ABSIS scores. Among the four variables the following six 
paths were hypothesized and tested: (1) ABSIS → DLQI 
(+); (2) ABSIS → EQ-5D-5L (−); (3) ABSIS → SWLS 
(−); (4) DLQI → EQ-5D-5L (−); (5) DLQI → SWLS (−) 
and (6) EQ-5D-5L → SWLS (+). To determine whether 
the expected model was plausible with the data, we used 
a Chi-square test statistic. The following goodness-of-fit 
indices were used based on Hu and Bentler’s recommenda-
tions: comparative fit index (CFI), root mean square error 
of approximation (RMSEA), and standardized root mean 
square residual (SRMR) [38]. A CFI of > 0.95 was consid-
ered as an indicative of good fit. Acceptable threshold values 
of RMSEA and SRMR were ≤ 0.06 and ≤ 0.08, respectively. 
p values less than 0.05 were taken as statistically significant. 
The path analysis was conducted using AMOS 23, all other 
analyses were performed using SPSS 25.0 (Armonk, NY: 
IBM Corp.).
Results
General characteristics
A total of 77 patients completed the SWLS, DLQI and EQ-
5D-5L questionnaires. Characteristics of the patient pop-
ulation are presented in Table 1. Mean age was 55.4 (SD 
14.8) years, and 58% were female. The majority of patients 
(73%) were diagnosed with pemphigus vulgaris and 26% 
with pemphigus foliaceus. One patient had IgA pemphigus. 
Mean ABSIS score of the study population was 11.7 (SD 
17.3). Based on ABSIS, 37 (48%), 20 (26%), 16 (21%) and 4 
(5%) patients were grouped into mild, moderate and signifi-
cant and extensive pemphigus subgroups. Mean EQ-5D-5L 
index and EQ VAS scores were 0.84 (0.22) and 69 (22), 
respectively.
Descriptive statistics of SWLS
Distribution of responses on the five items of SWLS is 
presented in Fig. 1. The highest rate of ‘strongly agree’ 
responses was found for items 1, 3 and 5 (19%), while the 
highest rate of ‘strongly disagree’ responses was observed 
for item 5. The mean SWLS total score in the sample was 
4.76 (SD 1.52). All five items exhibited very similar means: 
item 1: “In most ways, my life is close to my ideal” (4.83, 
SD 1.76), item 2: “The conditions of my life are excellent” 
(4.63, SD 1.80), item 3: “I am satisfied with my life” (4.92, 
SD 1.77), item 4:”So far I have gotten the important things 
I want in my life” (4.7, SD 1.58) and item 5: “If I could 
live my life over, I would change almost nothing” (4.55, 
SD 1.85).
Six (7.8%) patients indicated extreme dissatisfaction, five 
(6.5%) dissatisfaction, 14 (18.2%) slightly below average in 
life satisfaction, 16 (20.8%) average satisfaction, 21 (27.3%) 
high satisfaction and 15 (19.5%) very high satisfaction with 
their lives, respectively.
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Correlation analysis
Table 2 reports the correlations among ABSIS, DLQI, EQ-
5D-5L and SWLS total scores. Moderate correlations were 
found between ABSIS and DLQI (r = 0.425, p < 0.001), 
between DLQI and EQ-5D-5L (r = − 0.593, p < 0.001) 
and between EQ-5D-5L and SWLS (r = 0.465, p = 0.011). 
ABSIS demonstrated a weak correlation with EQ-5D-5L 
(r = − 0.345, p = 0.002) and with SWLS (r = − 0.237, 
p = 0.038). A weak correlation was detected between 
DLQI and SWLS (r = − 0.288, p = 0.011).
Subgroup analysis of SWLS
Table 3 presents the total SWLS scores in subgroups of 
patients based on gender, age, education and type of pem-
phigus. Slightly higher mean SWLS scores were observed in 
females (4.82), patents aged > 65 (4.91), those with a college 
or university degree (5.05) and pemphigus foliaceus patients 
(4.93); however, the differences were insignificant.
Results of the path analysis model
The path analysis model we evaluated is depicted in Fig. 2. 
The results indicate that there was a statistically significant 
path from ABSIS → DLQI → EQ-5D-5L → SWLS. The 
model showed overall good fit indices: Chi-square = 0.00 
CFI = 1.00, SRMR = 0.00. The model explained 18.0% of 
the variance of DLQI, 36.2% of the EQ-5D-5L and 22.3% 
of the SWLS.
ABSIS had a positive effect on DLQI (β = 0.425; 
p < 0.001) indicating that the disease severity assessed by 
the dermatologist affects the skin-specific HRQoL perceived 
by the patient. The ABSIS scores demonstrated no direct 
impact on EQ-5D-5L index scores (β = − 0.114; p = 0.262). 
An indirect path was detected between ABSIS and EQ-
5D-5L index through DLQI score. Contrary to our expecta-
tions, there was no direct relationship between ABSIS and 
SWLS (β = − 0.090; p = 0.428). DLQI had a negative effect 
on EQ-5D-5L (β = − 0.545; p < 0.001) implying that skin-
specific HRQoL did influence general HRQoL. There was 
no direct relationship between DLQI and SWLS (β = 0.011; 
p = 0.935). However, an indirect patch was detected by 
which the DLQI affected SWLS through the EQ-5D-5L. 
Finally, a significant relationship was found between EQ-
5D-5L and SWLS (β = 0.440; p < 0.001).
Discussion
The aim of the present study was to investigate life satis-
faction as a proxy for subjective well-being and its predic-
tors in pemphigus patients through a path analysis. The 
mean SWLS score was 4.76 indicating an overall average 
satisfaction with life. Nearly one-third (32.3%) of patients 
rated their satisfaction with their life to be ‘below average’. 
Life satisfaction was independent from patients’ age, gen-
der, level of education and type of disease. A path analysis 
revealed the following indirect path: ABSIS → DLQI → EQ-
5D-5L → SWLS. Physician’s objective assessment of disease 
severity (ABSIS) had no direct impact on life satisfaction. 
This route highlights the mediating effect of the patients’ 
perception about HRQoL on satisfaction with life.
Coping with the daily limitations caused by a chronic 
disease often affects patients’ perception of health and 
Table 1  General characteristics of the sample
a Combinations are possible
ABSIS Autoimmune Bullous Skin Disorder Intensity Score, DLQI 
Dermatology Life Quality Index, SWLS Satisfaction with Life Scale
Characteristics N (%) or mean (SD)
Number of subjects 77
Age (years) 55.4 (14.8)
Female 45 (58.4%)
Education
 Primary school 13 (16.9%)
 High school 42 (54.5%)
 College/university 22 (28.6%)
Employmenta
 Employed full-time 29 (37.7%)
 Employed part-time 8 (10.4%)
 Unemployed 4 (5.2%)
 Disability pensioner 12 (15.6%)
 Retired 27 (35.1%)
 Student 1 (1.3%)
 Other 1 (1.3%)
Disease duration (years) 4.4 (5.3)
Type of pemphigus
 Pemphigus vulgaris 56 (72.7%)
 Pemphigus foliaceus 20 (26.0%)
 IgA pemphigus 1 (1.3%)
ABSIS (0–206) 12.6 (18.9%)
Severity groups
 Limited (ABSIS 0–3) 37 (48.1%)
 Moderate (ABSIS 4–16) 20 (26.0%)
 Significant (ABSIS 17–52) 16 (20.8%)
 Extensive (ABSIS 53–206) 4 (5.2%)
DLQI (0–30) 5.36 (6.88)
EQ-5D-5L (–0.285–1) 0.84 (0.22)
Current treatment
 None 2 (2.6%)
 Topical therapy (only) 7 (9.1%)
 Systemic  therapya 68 (88.3%)
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satisfaction with life [39]. Previous research has shown 
significantly lower life satisfaction in patients with vari-
ous chronic skin diseases [19–25]. For example, 16.6% of 
patients with atopic dermatitis in the US reported being 
at least somewhat dissatisfied with life [25]. In our study, 
14.3% of patients declared to be dissatisfied or highly dis-
satisfied. A potential explanation for this could be that 
Fig. 1  Distribution of the responses on the five items of SWLS. SWLS Satisfaction with Life Scale
Table 2  Correlation matrix of 
the outcome measures
For ABSIS and DLQI, higher scores represent worse health status and for EQ-5D-5L and SWLS higher 
scores refer to better health status/satisfaction with life
ABSIS Autoimmune Bullous Skin Disorder Intensity Score, DLQI Dermatology Life Quality Index, SWLS 
Satisfaction with Life Scale
ABSIS DLQI EQ-5D-5L
ABSIS (0–206) – – –
DLQI (0–30) 0.425 (p < 0.001) – –
EQ-5D-5L (–0.285–1) − 0.345 (p = 0.002) − 0.593 (p < 0.001) –
SWLS (1–7) − 0.237 (p = 0.038) − 0.288 (p = 0.011) 0.465 (p = 0.011)
Table 3  SWLS scores in subgroups of patients
SWLS Satisfaction with Life Scale
Mean (SD) Median (IQR) p value
Gender 0.688
 Male 4.68 (1.34) 4.90 (2.05)
 Female 4.82 (1.65) 5.20 (2.40)
Age groups 0.181
 18–45 5.22 (1.45) 5.3 (1.8)
 46–65 4.45 (1.59) 4.7 (2.2)
 66– 4.91 (1.39) 5.2 (2.3)
Education 0.577
 Primary 4.58 (2.11) 4.80 (4.00)
 Secondary 4.66 (1.46) 4.80 (2.20)
 Tertiary 5.05 (1.25) 5.20 (1.75)
Type of pemphigus 0.562
 Pemphigus vulgaris 4.70 (1.59) 5.00 (2.20)
 Pemphigus foliaceus 4.93 (1.34) 5.00 (2.20)
Fig. 2  Path model. Notes: every path coefficient is standardized 
(*p < 0.001). Dashed lines represent insignificant paths. ABSIS Auto-
immune Bullous Skin Disorder Intensity Score, DLQI Dermatology 
Life Quality Index, SWLS Satisfaction with Life Scale
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the majority of patients were well-treated and indicated 
a relatively low disease severity and less deterioration in 
their HRQoL, which was very likely responsible for the 
rather positive results regarding life satisfaction.
Earlier research suggests a good validity of the EQ-
5D-5L in pemphigus patients [8]. Nevertheless, it may fail 
to capture some of the broader impact of pemphigus on 
HRQoL and subjective well-being [11]. For example, in a 
recent survey among members of the general population in 
the UK, respondents identified several important aspects 
of health that are not covered by the five dimensions of the 
EQ-5D, such as mental and emotional health and happi-
ness [40]. Non-health outcomes including ability to work, 
financial security and social support in one’s life might be 
important determinants of life satisfaction.
A practical implication of our study is that objective 
perception of the physician on disease severity only has an 
indirect effect on satisfaction with life. In routine practice, 
disease severity and HRQoL instruments regularly used to 
assess patients’ health status may be complemented with a 
measure of subjective well-being, such as SWLS to achieve 
a more holistic assessment of patients’ lives and optimise 
pemphigus care. This would also enable the use of subjec-
tive well-being outcomes to aid health policy decisions.
This is the first study in the literature to report on life 
satisfaction in pemphigus patients. Furthermore, our anal-
yses were based on a relatively large number of patients, 
considering the rarity of the disease. Among the study’s 
limitations, it needs to be acknowledged that the study was 
conducted in university dermatology departments, and sys-
tematic selection bias due to centre effects could have been 
present. Thus, the results may not be representative of the 
entire population of patients with pemphigus. However, 
the study population included a large variety of pemphi-
gus patients in terms of clinical characteristics and severity. 
Second, many other factors possibly influencing life satisfac-
tion have not been measured in this survey. Further research 
is required to identify unexplored the drivers of subjective 
well-being in pemphigus patients.
In conclusion, an overall average satisfaction with life 
was identified in patients with pemphigus. A higher level 
of general HRQoL is the major determinant of life satis-
faction in pemphigus patients. The path analysis identified 
skin-specific HRQoL and disease severity as indirect predic-
tors of satisfaction with life. These results underscore the 
importance of achieving remission in benefiting the lives of 
patients with pemphigus.
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